Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Significance: Parkinson’s disease (PD)-linked familial mutations in LRRK2 impact its enzymatic activity by commonly increasing kinase activity, either directly within the kinase domain or indirectly via the GTPase domain by impairing GTP hydrolysis. Familial LRRK2 mutations also commonly promote neuronal toxicity in cultured cells, and for the common G2019S mutation, these effects are kinase dependent. The mechanisms underlying familial LRRK2 mutations in animal models are uncertain, due to the general lack of robust phenotypes. Our study demonstrates important roles for kinase and GTPase activities in mediating the neurodegenerative effects of G2019S LRRK2 in rodents, highlighting both as promising therapeutic targets for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · cited 1×
“Genome-wide association studies further link common variants at the LRRK2 locus with increased risk for sporadic PD (7, 8).”
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228 · cited 1×
“Familial PD-linked mutations in LRRK2 commonly increase its kinase activity in mammalian cells to varying degrees and promote substrate phosphorylation (i.e., a subset of Rab GTPases) and autophosphorylation (i.e., at Ser1292) (17 – 19).”
Self-citationA meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112 · cited 1×
“Genome-wide association studies further link common variants at the LRRK2 locus with increased risk for sporadic PD (7, 8).”
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859 · cited 1×
“P disease (PD) typically occurs in a sporadic manner through a complex interaction between genetic risk, aging, and environmental exposure (1).”
Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · cited 1×
“In contrast, G2019S LRRK2 specifically increased APP-positive inclusions in the ipsilateral striatum, a sensitive marker of axonal damage (43, 44), that is absent with WT or G2019S/K1906M LRRK2 variants ( SI Appendix , Fig.”
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619 · cited 1×
“For example, many studies have routinely employed kinase-inactive mutations at the kinase proton acceptor site (D1994) to block neuronal damage in primary culture models induced by PD-linked mutant LRRK2 (25-30).”
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
Hernandez, D. G., Reed, X., & Singleton, A. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13593 · Cited by 448 · cited 1×
“A small proportion of PD cases are inherited and are known to be caused by mutations in at least 14 different genes (2).”
Ramonet, D., Daher, J. P. L., Lin, B. M., Stafa, K., Kim, J., Banerjee, R., Westerlund, M., Pletnikova, O., Glauser, L., Yang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018568 · Cited by 405 · cited 1×
“nigra dopaminergic neurons was performed using the optical fractionator probe of the StereoInvestigator software (MicroBrightField Biosciences), as described (32, 35, 44).”
Self-citationParkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
Tsika, E., Glauser, L., Moser, R., Fiser, A., Daniel, G., Sheerin, U.-M., Lees, A., Troncoso, J. C., Lewis, P. A., Bandopadhyay, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu178 · Cited by 159 · cited 2×
“In contrast, G2019S LRRK2 specifically increased APP-positive inclusions in the ipsilateral striatum, a sensitive marker of axonal damage (43, 44), that is absent with WT or G2019S/K1906M LRRK2 variants (SI Appendix, Fig.”
Self-citation
Cited by
Primary cilia and ciliary signaling pathways in aging and age-related brain disorders
Ma, R., Kutchy, N. A., Chen, L., Meigs, D. D., & Hu, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105607 · Cited by 114
Yang, J., Luly, K. M., & Green, J. J. (2023) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1853 · Cited by 40
Lara Ordóñez, A. J., Fasiczka, R., Fernández, B., Naaldijk, Y., Fdez, E., Blanca Ramírez, M., Phan, S., Boassa, D., & Hilfiker, S. (2022) · Biology Open · doi:10.1242/bio.059468 · Cited by 28
Metadata
- Authors
- Nguyen, A. P. T., Tsika, E., Kelly, K., Levine, N., Chen, X., West, A. B., Boularand, S., Barneoud, P., & Moore, D. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2020-07-06
- Volume
- 117
- Issue
- 29
- Pages
- 17296-17307
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3038193344
- Cited by
- 68
- References
- 10
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. https://app.cochat.ai/papers/10.1073/pnas.1922184117
- The paper
- Nguyen, A. P. T., Tsika, E., Kelly, K., Levine, N., Chen, X., West, A. B., Boularand, S., Barneoud, P., & Moore, D. J. (2020). Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1922184117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.